Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01793233 · ClinicalTrials.gov registry record
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 203
- Enrollment target
NCT01793233 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 203 participants.
The verdict
NCT01793233 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 203 participants
- Enrollment target
Study Summary
This clinical trial studies blood sample markers of reproductive hormones in assessing ovarian reserve in younger patients with newly diagnosed lymphomas. Studying samples of blood from patients with cancer in the laboratory may help measure the effect of curative therapy for lymphoma on ovarian failure.
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Questionnaire Administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2013-06-17 |
| Est. Completion | 2024-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01793233
The ClinicalTrials.gov registry entry for NCT01793233 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT01793233 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01793233 about?
NCT01793233 is a clinical study titled "Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas". This clinical trial studies blood sample markers of reproductive hormones in assessing ovarian reserve in younger patients with newly diagnosed lymphomas. Studying samples of blood from patients with cancer in the laboratory may help measure the effect of curative therapy for lymphoma on ovarian fai...
What is the current status of trial NCT01793233?
This trial is currently completed. The enrollment target is 203 participants. The study started on 2013-06-17. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT01793233?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT01793233?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.